Press releases and news from regional sources, click on original post link to read the full article and see what’s trending. Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Iambic Presents Updated IAM1363 Clinical Data at ESMO 2026, Showing Durable Responses with a Favorable Tolerability Profile in Heavily Pretreated Participants with HER2-Driven Cancers
SAN DIEGO–(BUSINESS WIRE)–Iambic Therapeutics, Inc. (Iambic) (Nasdaq: IAM), a clinical-stage life sciences and technology company developing novel medicines using its AI-driven platform, today announced updated clinical data for IAM1363, a selective and brain-penetrant HER2 tyrosine […]
